As I've said before, innovation is the lifeblood of the American economy. However, without the support of a dedicated workforce and sound public policy, innovation cannot occur. When most people think about the pharmaceutical workforce they think of chemists and lab technicians, but the 3.2 million American jobs created by the pharmaceutical industry come from a diverse range of sectors. From construction workers and engineers who build the facilities to the sanitation workers, groundskeepers and administrative professionals who keep the plants running, the Pharmaceutical Industry Labor-Management Association (PILMA) represents an association of workers and employers that are vital part of the workforce that makes medical progress possible.
An article and video on PILMA's website highlight the importance of the life sciences industry in Lilly's home state of Indiana. The article discusses an event held at the Iron Workers Local Union 22 in Indianapolis, which brought together leaders from industry, labor and government to focus on job creation and innovation Indiana's bioscience sector. In attendance was U.S. Representative Andre Carson who stated, "The life sciences sector offers one of the best opportunities to jump start this economic recovery."
Eli Lilly and Company is the 6th largest employer in the state of Indiana. Innovation supports these jobs, and these jobs support innovation. A policy environment that promotes a sustainable and growing biopharmaceutical industry helps to promote medical progress and keep jobs in the United States. As PILMA's website says, "If the U.S. is to remain competitive, it is imperative that life science industry leaders, such as Indiana, secure their position as a center of innovation. "